This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Trident Pharmaceuticals, Inc.. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: The Innovative Contributions of Andrew Morgan
Introduction
Andrew Morgan is a notable inventor based in Henleaze, GB. He has made significant strides in the field of immunology, particularly with his innovative approach to vaccine development. His work has the potential to enhance the effectiveness of vaccines administered to mammalian subjects.
Latest Patents
Andrew Morgan holds a patent for a method aimed at stimulating the immune response to a vaccine. This method involves administering an effective amount of EtxB or a molecule with substantially equivalent activity, which is free from whole toxin and not linked to an antigen. This innovative approach could lead to advancements in vaccine efficacy and safety.
Career Highlights
Morgan is currently associated with Trident Pharmaceuticals, Inc., where he continues to contribute to the field of pharmaceutical research and development. His expertise in immunology and vaccine technology has positioned him as a valuable asset in his organization.
Collaborations
Throughout his career, Andrew has collaborated with notable colleagues, including Timothy Raymond Hirst and Neil Andrew Williams. These collaborations have likely fostered an environment of innovation and shared knowledge, further enhancing the impact of their work.
Conclusion
Andrew Morgan's contributions to vaccine development exemplify the importance of innovation in the field of immunology. His patent and ongoing work at Trident Pharmaceuticals, Inc. highlight his commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile